Paid Clinical Trials in High Point, NC

Browse 24 Paid Studies High Point Across 514 Cities
19 Phase 3 Trial · 1162 Paid Studies High Point Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Paid Clinical Trials in High Point, NC

Reviewed by Michael Gill, B. Sc.

Image of Dermatology Consulting Services, PLLC in High Point, United States.

Active Armfor Scalp Psoriasis

This trial tests a lotion to improve hair growth, reduce scalp itch, and improve scalp psoriasis in 12 weeks. Patients' perceptions of the lotion's value are also assessed.

Dermatology Consulting Services, PLLCZoe D Draelos, MDOrtho Dermatologics

Image of Synergy Research Centers - Synergy San Diego in Lemon Grove, United States.

TNX-1900 High Dosefor Migraine

Lemon Grove, CA

This trial tests two doses of a new drug for people with chronic migraine to see how safe and effective it is.

Synergy Research Centers - Synergy San Diego (+25 Sites)Gregory Sullivan, MDTonix Pharmaceuticals, Inc.

Image of Om Research LLC in Lancaster, United States.

Guselkumab Dose 1for Ulcerative Colitis

This trial will test if the drug guselkumab is effective in treating ulcerative colitis.

Om Research LLC (+17 Sites)Janssen Research & Development, LLC Clinical trialJanssen Research & Development, LLC

Image of Tulane University Medical Center in New Orleans, United States.

ECLIPSE PV / A22-203

18 - No maximum age

New Orleans, LA

This triallooks at how a drug affects people with a blood disorder called polycythemia vera, to assess safety and effectiveness.

Tulane University Medical Center (+24 Sites)Ray Urbanski, MD, PhDPharmaEssentia

Image of Bausch Site 501 in New Orleans, United States.

Rifaximin SSDfor Encephalopathy

New Orleans, LA

This trial will test whether rifaximin can help delay the first episode of overt hepatic encephalopathy (OHE) in people with advanced liver cirrhosis.

Bausch Site 501 (+66 Sites)Michael MaderBausch Health Americas, Inc.

Image of Om Research LLC in Lancaster, United States.

Guselkumab Dose 3for Crohn's Disease

This trial will test whether the drug guselkumab is effective and safe for people with Crohn's disease.

Waitlist Available

Om Research LLC (+32 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC

Image of Alaska Oncology and Hematology, LLC. in Anchorage, United States.

Pembrolizumabfor Non-Small Cell Lung Cancer

This trial is testing a new combination therapy for advanced or metastatic non-small-cell lung cancer (NSCLC) that has not responded to other treatments. The primary objectives are to assess the objective response rate (ORR) and to determine the recommended Phase 2 dose (RP2D) of the new therapy.

Alaska Oncology and Hematology, LLC. (+23 Sites)Gilead Study DirectorGilead Sciences

Image of Bausch Site 001 in Palmetto Bay, United States.

Rifaximin SSDfor Encephalopathy

Palmetto Bay, FL

This trial is testing whether a drug can help prevent hepatic encephalopathy, a complication of liver cirrhosis, in people who have not had it before.

FDA Approved Drug

Bausch Site 001 (+91 Sites)John LaheyBausch Health Americas, Inc.

Image of Novartis Investigative Site in Little Rock, United States.

LOU064 (open-label)for Chronic Urticaria

Little Rock, AR

This trial will compare the effects of remibrutinib to placebo in adults with CSU that is not well controlled by H1-antihistamines.

Waitlist Available

Novartis Investigative Site (+47 Sites)Novartis PharmaceuticalsNovartis Pharmaceuticals

Image of University of Alabama-The Kirklin Clinic in Birmingham, United States.

Mirikizumabfor Crohn's Disease

This trial is testing a new drug for Crohn's Disease to see if it is safe and effective.

Waitlist Available

FDA Approved Drug

University of Alabama-The Kirklin Clinic (+99 Sites)Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM -5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company

10 Paid Studies High Point Near Me

Top Cities for Paid Studies High Point

Image of Miami in Florida.

Miami

26Active Trials

Novartis Investigative SiteTop Active Site

Image of Houston in Texas.

Houston

19Active Trials

MD AndersonTop Active Site

Paid Studies High Point by Phase of Trial

N/A Paid Studies High Point

1Active Paid Studies High Point

1Number of Unique Treatments

1Number of Active Locations

Combined tDCS and PNE

Most Recent Paid Studies High Point

Clinical Trial

Began Recruiting Date

Phase

Active Arm for Scalp Psoriasis

6/1/2023

Phase 4

TNX-1900 High Dose for Migraine

12/6/2022

Phase 2

P1101 250-350-500mcg for Polycythemia Vera

10/26/2022

Phase 3

Difamilast Ointment for Atopic Dermatitis

10/1/2022

Phase 3

Guselkumab Dose 1 for Ulcerative Colitis

9/13/2022

Phase 3

About The Author

Michael Gill - B. Sc.

First Published: October 12th, 2021

Last Reviewed: August 22nd, 2023

References¹ Pérez-García J, Soberino J, Racca F, Gion M, Stradella A, Cortés J. Atezolizumab in the treatment of metastatic triple-negative breast cancer. Expert Opin Biol Ther. 2020 Sep;20(9):981-989. doi: 10.1080/14712598.2020.1769063. Epub 2020 May 25. Review. https://pubmed.ncbi.nlm.nih.gov/32450725² Perez-Garcia J, Soberino J, Racca F, Gion M, Stradella A, Cortes J. Atezolizumab in the treatment of metastatic triple-negative breast cancer. Expert Opin Biol Ther. 2020 Sep;20(9):981-989. doi: 10.1080/14712598.2020.1769063. Epub 2020 May 25. https://pubmed.ncbi.nlm.nih.gov/32450725³ Tsimikas S, Reeves RR, Patel MP. Always Present, But Now Rediscovered: Lp(a) as a Predictor of Long-Term Outcomes in PCI. JACC Cardiovasc Interv. 2021 Sep 27;14(18):2069-2072. doi: 10.1016/j.jcin.2021.08.032. No abstract available. https://pubmed.ncbi.nlm.nih.gov/34556281⁴ Plakogiannis R, Sorbera M, Fischetti B, Chen M. The Role of Antisense Therapies Targeting Lipoprotein(a). J Cardiovasc Pharmacol. 2021 Jul 1;78(1):e5-e11. doi: 10.1097/FJC.0000000000001045. https://pubmed.ncbi.nlm.nih.gov/34232223⁵ Plakogiannis R, Sorbera M, Fischetti B, Chen M. The Role of Antisense Therapies Targeting Lipoprotein(a). J Cardiovasc Pharmacol. 2021 Jul 1;78(1):e5-e11. doi: 10.1097/FJC.0000000000001045. Review. https://pubmed.ncbi.nlm.nih.gov/34232223⁶ Tsimikas S, Reeves RR, Patel MP. Always Present, But Now Rediscovered: Lp(a) as a Predictor of Long-Term Outcomes in PCI. JACC Cardiovasc Interv. 2021 Sep 27;14(18):2069-2072. doi: 10.1016/j.jcin.2021.08.032. https://pubmed.ncbi.nlm.nih.gov/34556281

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security